Ace Medical Technology Co., Ltd.
Update：2026/09/15
Industries
Main Industry
Health Care
Main Product/Service
Ace Medical Technology Co., Ltd. primarily develops bare electrodes for in vitro monitoring systems, as well as circulating tumor cell (CTC) counting, purification, and separation system instruments. Compared with existing carbon and gold electrodes, the bare electrodes for in vitro monitoring systems offer the advantages of high stability and low cost, giving them strong international competitiveness in the in vitro monitoring electrode test strip market.
In addition, regarding the cell analysis and separation instruments developed by Ace Medical Technology Co., Ltd., these instruments feature high cell processing throughput, low cell loss rate, and high cell separation purity. Furthermore, the separation process does not affect cell viability, allowing for the precise isolation of target cells by identifying cell surface proteins. This supports downstream analysis of genes and proteins related to live cells, representing a breakthrough technology in the life science research and cell detection markets.
(The content above was translated by AI.)
In addition, regarding the cell analysis and separation instruments developed by Ace Medical Technology Co., Ltd., these instruments feature high cell processing throughput, low cell loss rate, and high cell separation purity. Furthermore, the separation process does not affect cell viability, allowing for the precise isolation of target cells by identifying cell surface proteins. This supports downstream analysis of genes and proteins related to live cells, representing a breakthrough technology in the life science research and cell detection markets.
(The content above was translated by AI.)
Founded Year
2018
Unified Business No.
50769456
Status
Closed
Number of Employees
0
Total Paid-in
Capital
204,000,000 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Jinhong Medical Technology has a strong and complete team, with members encompassing professionals in the fields of biology, medicine, mechanics, electronic control, software, and intellectual property. In addition to meeting the general requirements of the market, the company insists that product quality must exceed market standards. Therefore, besides holding relevant certifications such as ISO13485, TAF, GMP, and CE, Jinhong has invested a large number of PhDs and industry personnel with over 20 years of relevant experience in research, development, and production. With the company goals of supporting production through R&D and refining R&D through production, the company expects all of its products to reach the highest market quality standard of "Gold (Ace)". Jinhong Medical Device is an international company with locations and personnel in Mainland China, Southeast Asia, Europe, and America. In coordination with the global patent layout of its product technologies, the company exports its products worldwide. At the same time, under the trends of the popularization of medicine and the prevalence of cancer, the company manufactures highly cost-effective products to make them affordable for the general public, dedicating itself to popularizing cancer detection and prognosis among the masses. This is both Jinhong's social responsibility and its mission.
Our company's environmentally friendly dry vacuum sputtering technology poses no concerns of environmental pollution. In addition to reducing the cost of pollution treatment, it is produced using a roll-to-roll method, which offers the advantage of mass production, significantly reducing production costs and effectively increasing competitiveness. If the advantages of roll-to-roll production can be further utilized to carry out all subsequent processes in a continuous production manner, its competitiveness will be further enhanced.
In addition, our company possesses innovative microfluidic cell counting and separation system instrument technology. These system instruments can be widely applied in basic life science research and cell detection-related markets.
(The content above was translated by AI.)
Our company's environmentally friendly dry vacuum sputtering technology poses no concerns of environmental pollution. In addition to reducing the cost of pollution treatment, it is produced using a roll-to-roll method, which offers the advantage of mass production, significantly reducing production costs and effectively increasing competitiveness. If the advantages of roll-to-roll production can be further utilized to carry out all subsequent processes in a continuous production manner, its competitiveness will be further enhanced.
In addition, our company possesses innovative microfluidic cell counting and separation system instrument technology. These system instruments can be widely applied in basic life science research and cell detection-related markets.
(The content above was translated by AI.)
